- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03264261
Constraint Induced Movement Therapy for Walking in Individuals Post Stroke
February 14, 2024 updated by: Ming Wu, Shirley Ryan AbilityLab
To compare the effect of constraint induced movement therapy (CIMT) vs. treadmill training only on walking function in individuals post-stroke, a 6 week, single-blind, randomized training study will be conducted with three assessments of gait to determine the training effect.
Subjects will be randomized to either the CIMT or treadmill training only groups at the initial test.
Following the initial test, individuals from the 2 groups will undergo intensive locomotor training.
Training will be performed 3 times per week for 6 weeks with the training time for each visit set to 45 minutes as tolerated.
Data collection will proceed until 36 subjects from 2 groups have been trained.
Study Overview
Status
Recruiting
Conditions
Intervention / Treatment
Detailed Description
To determine the effect of constraint induced movement therapy (CIMT) on locomotor function in individuals post stroke.
In order to compare the effect of CIMT vs. treadmill training only on walking function in individuals post-stroke, a 6 week, single-blind, randomized training study will be conducted with three assessments of gait to determine the training effect.
Subjects will be blocked by gait speed into slow (< 0.4 m/s) or fast (≥ 0.4 m/s) subgroups and randomized to either the CIMT or treadmill training only groups at the initial test.
Following the initial test, individuals from the 2 groups will undergo intensive locomotor training.
Training will be performed 3 times per week for 6 weeks with the training time for each visit set to 45 minutes as tolerated, excluding set up time.
Data collection will proceed until 36 subjects from 2 groups have been trained.
Study Type
Interventional
Enrollment (Estimated)
36
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Weena Dee, PT
- Phone Number: 312-238-7503
- Email: wdee@ric.org
Study Locations
-
-
Illinois
-
Chicago, Illinois, United States, 60611
- Recruiting
- Abilitylab
-
Contact:
- Weena Dee, PT
- Phone Number: 312-238-7503
- Email: wdee@sralab.org
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
21 years to 75 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- age between 21 and 75 years;
- history of unilateral, supratentorial, ischemic or hemorrhagic stroke;
- no prior stroke;
- demonstration of impaired walking function (self-selected walking speed ≤ 0.80 m/s);
- able to stand and walk (>10 meters) without physical assistance.
Exclusion Criteria:
- significant cardiorespiratory/metabolic disease;
- other neurological or orthopedic injury that impairs locomotion;
- scores on the Mini Mental Status examination < 24;
- stroke of the brainstem or cerebellar lesions;
- uncontrolled hypertension (systolic > 200 mm Hg, diastolic > 110 mm Hg);
- botox injection within 6 months of starting the study.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: robotic training
For the robotic training group, a controlled resistance load will be applied to the unaffected leg at the ankle and an assistance load will be applied to the pelvis.
|
robotic training, 3 times/week for 6 weeks
|
Active Comparator: treadmill training
For the treadmill training only group, a physical therapist will provide manual assistance to the affected leg at the knee and/or ankle joints as necessary during treadmill training.
|
treadmill training only, 3 times/week for 6 weeks
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in walking speed
Time Frame: pre, post 6 weeks training, and 8 weeks after the end of training.
|
Overground gait speed will be collected on a 10 m instrumented walkway
|
pre, post 6 weeks training, and 8 weeks after the end of training.
|
Change in 6-minute walking distance
Time Frame: pre, post 6 weeks training, and 8 weeks after the end of training.
|
walking distance covered by subjects in 6 minutes
|
pre, post 6 weeks training, and 8 weeks after the end of training.
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in Berg Balance Scale
Time Frame: pre, post 6 weeks training, and 8 weeks after the end of training.
|
Berg Balance Scale scores will be collected by research physical therapist
|
pre, post 6 weeks training, and 8 weeks after the end of training.
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Ming Wu, PhD, Abilitylab
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
August 14, 2017
Primary Completion (Estimated)
October 30, 2024
Study Completion (Estimated)
October 30, 2024
Study Registration Dates
First Submitted
August 14, 2017
First Submitted That Met QC Criteria
August 24, 2017
First Posted (Actual)
August 29, 2017
Study Record Updates
Last Update Posted (Actual)
February 15, 2024
Last Update Submitted That Met QC Criteria
February 14, 2024
Last Verified
March 1, 2023
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- R01HD082216 (U.S. NIH Grant/Contract)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
Yes
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Stroke
-
University Hospital, GhentRecruitingStroke | Stroke, Ischemic | Stroke, Acute | Stroke Sequelae | Stroke HemorrhagicBelgium
-
Moleac Pte Ltd.RecruitingStroke | Stroke, Ischemic | Stroke Sequelae | Stroke, Cardiovascular | Strokes Thrombotic | Stroke, Embolic | Stroke, CryptogenicSingapore, Philippines
-
Moleac Pte Ltd.Not yet recruitingStroke | Stroke, Ischemic | Stroke Sequelae | Stroke, Cardiovascular | Strokes Thrombotic | Stroke, Embolic | Stroke, Cryptogenic
-
IRCCS San Camillo, Venezia, ItalyRecruitingStroke | Stroke, Ischemic | Stroke Sequelae | Stroke HemorrhagicItaly
-
Vanderbilt University Medical CenterPatient-Centered Outcomes Research Institute; University of Alabama at BirminghamEnrolling by invitationStroke | Stroke, Ischemic | Stroke, Acute | Stroke Sequelae | Engagement, Patient | Stroke HemorrhagicUnited States
-
University of MinnesotaAmerican Occupational Therapy FoundationRecruitingStroke | Stroke Sequelae | Stroke Hemorrhagic | Stroke IschemicUnited States
-
University of British ColumbiaCanadian Institutes of Health Research (CIHR); Michael Smith Foundation for...RecruitingStroke | Stroke, Ischemic | Stroke Hemorrhagic | Chronic StrokeCanada
-
University of CincinnatiMedical University of South Carolina; University of California, Los Angeles; University...RecruitingStroke | Stroke, Ischemic | Stroke, Acute | Stroke HemorrhagicUnited States
-
University of LiegeCompletedStroke, Acute | Stroke Hemorrhagic | Stroke, ComplicationBelgium
-
Turkish Stroke Research and Clinical Trials NetworkElectroCore INC; Turkish Neurological SocietyCompletedStroke | Stroke, Ischemic | Stroke, Acute | Stroke, HemorrhagicTurkey
Clinical Trials on robotic training
-
Chang Gung Memorial HospitalCompletedChronic StrokeTaiwan
-
The Hong Kong Polytechnic UniversityCompleted
-
City University of New YorkBronx Veterans Medical Research Foundation, IncTerminatedSpinal Cord Injuries | Tetraplegia/Tetraparesis | Paraplegia, Spinal | Paraplegia, SpasticUnited States
-
University of CalgaryRecruitingCerebral Palsy | Brain Injuries | Spinal Cord Injuries | Mobility Limitation | Spina BifidaCanada
-
Indiana UniversityTerminatedTBI (Traumatic Brain Injury)United States
-
University of BernRecruitingStroke | Neurologic DisorderSwitzerland
-
National University Hospital, SingaporeTemasek Foundation CaresCompletedStroke | Spinal Cord Diseases | Spinal Cord InjuriesSingapore
-
Baylor Research InstituteUnited States Department of Defense; Texas Woman's UniversityRecruitingSpinal Cord InjuriesUnited States
-
City University of New YorkIcahn School of Medicine at Mount Sinai; Bronx Veterans Medical Research Foundation...RecruitingSpinal Cord Injuries | Tetraplegia/Tetraparesis | Paraplegia, Spinal | Paraplegia, SpasticUnited States